Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 5/20 | 0.67 |
| ▸ | NPC1 | O15118 | 4/20 | 0.67 |
| ▸ | RAB9A | P51151 | 3/20 | 0.67 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.67 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.67 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.67 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.67 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.66 |
| ▸ | TP53 | P04637 | 4/20 | 0.66 |
| ▸ | MEN1 | O00255 | 4/20 | 0.66 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.66 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.66 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.66 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.66 |
| ▸ | MAPT | P10636 | 3/20 | 0.66 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.66 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.66 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.66 |
| ▸ | RECQL | P46063 | 1/20 | 0.66 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31061270 | 1.00 | HPGD (0.67) | HPGDNPC1RAB9ASMN1; SMN2AKR1C3 | |
| SCHEMBL17786570 | 0.85 | EGFR (0.58) | HPGDNPC1RAB9ASMN1; SMN2AKR1C3 | |
| SCHEMBL25186939 | 0.83 | HPGD (0.67) | HPGDNPC1RAB9ASMN1; SMN2AKR1C3 | |
| SCHEMBL1974743 | 0.83 | HPGD (0.61) | HPGDNPC1RAB9ASMN1; SMN2AKR1C3 | |
| SCHEMBL5468830 | 0.82 | MAOB (0.62) | HPGDNPC1RAB9ACYP3A4TP53 | |
| SCHEMBL30956969 | 0.82 | MAOB (0.62) | HPGDNPC1RAB9ACYP3A4TP53 | |
| SCHEMBL4634256 | 0.81 | HPGD (0.73) | HPGDNPC1RAB9ASMN1; SMN2AKR1C3 | |
| SCHEMBL9080220 | 0.81 | AKR1C3 (0.72) | HPGDNPC1RAB9ASMN1; SMN2AKR1C3 | |
| SCHEMBL3205778 | 0.80 | HPGD (0.67) | HPGDNPC1RAB9ASMN1; SMN2AKR1C3 | |
| SCHEMBL312255 | 0.80 | AKR1C3 (1.00) | HPGDNPC1RAB9ASMN1; SMN2AKR1C3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 254 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11596657-B2 | Use of AhR agonist for the preventive or curative treatment of metabolic syndrome and the associated disorders | INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE (FR) | 2023-03-07 | — | — | US | claimed |
| US-20220143143-A1 | USE OF ACTIVATORS OF THE ARYL HYDROCARBON RECEPTOR FOR TREATING GLUTEN-INDUCED GASTROINTESTINAL DISEASES | UNIV MCMASTER (CA) | 2022-05-12 | — | — | US | claimed |
| EP-3920908-A1 | USE OF ACTIVATORS OF THE ARYL HYDROCARBON RECEPTOR FOR TREATING GLUTEN-INDUCED GASTROINTESTINAL DISEASES | McMaster University (CA) | 2021-12-15 | — | — | EP | claimed |
| WO-2020160680-A1 | USE OF ACTIVATORS OF THE ARYL HYDROCARBON RECEPTOR FOR TREATING GLUTEN-INDUCED GASTROINTESTINAL DISEASES. | MCMASTER UNIVERSITY (CA) | 2020-08-13 | — | — | WO | claimed |
| US-10736927-B2 | Pharmaceutical compositions for preventing or treating inflammatory bowel diseases | INSERM (INSTITUTE NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MEDICALE) (FR) | 2020-08-11 | — | — | US | claimed |
| US-20190282638-A1 | USE OF AHR AGONIST FOR THE PREVENTIVE OR CURATIVE TREATMENT OF METABOLIC SYNDROME AND THE ASSOCIATED DISORDERS | INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE, L'ALIMENTATION ET L'ENVIRONNEMENT (FR) | 2019-09-19 | — | — | US | claimed |
| EP-3522902-A1 | USE OF AHR AGONIST FOR THE PREVENTIVE OR CURATIVE TREATMENT OF METABOLIC SYNDROME AND THE ASSOCIATED DISORDERS | Institut National de la Recherche Agronomique (FR) | 2019-08-14 | — | — | EP | claimed |
| US-20180250350-A1 | PHARMACEUTICAL COMPOSITIONS FOR PREVENTING OR TREATING INFLAMMATORY BOWEL DISEASES | INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE, L'ALIMENTATION ET L'ENVIRONNEMENT (FR) | 2018-09-06 | — | — | US | claimed |
| EP-3337492-A1 | PHARMACEUTICAL COMPOSITIONS FOR PREVENTING OR TREATING INFLAMMATORY BOWEL DISEASES | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2018-06-27 | — | — | EP | claimed |
| WO-2018065132-A1 | USE OF AHR AGONIST FOR THE PREVENTIVE OR CURATIVE TREATMENT OF METABOLIC SYNDROME AND THE ASSOCIATED DISORDERS. | INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE (FR) | 2018-04-12 | — | — | WO | claimed |
| EP-3167892-A1 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR PREVENTING OR TREATING IMFLAMMATORY BOWEL DISEASES | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2017-05-17 | — | — | EP | claimed |
| US-20170121678-A1 | METHODS AND COMPOSITIONS TO STABILIZE DIFFERENT STEM CELL STATES | UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION | 2017-05-04 | — | — | US | claimed |
| WO-2017032739-A1 | PHARMACEUTICAL COMPOSITIONS FOR PREVENTING OR TREATING INFLAMMATORY BOWEL DISEASES | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2017-03-02 | — | — | WO | claimed |
| CN-104471391-B | Differentiate that there is the method for the part of the AHR receptor of therapeutic sebum suppression activity and described part | 赛斯安制药公司 | 2016-12-07 | — | — | CN | claimed |
| WO-2015187689-A1 | METHODS AND COMPOSITIONS TO STABILIZE DIFFERENT STEM CELL STATES | UNIVERSITY OF WASHINGTON - CENTER FOR COMMERCIALIZATION (US) | 2015-12-10 | — | — | WO | claimed |
| EP-2850429-A1 | METHOD FOR IDENTIFYING LIGANDS OF THE AHR RECEPTOR HAVING THERAPEUTIC SEBOSUPPRESSIVE ACTIVITY, AND SAID LIGANDS | Thesan Pharmaceuticals, Inc. (US) | 2015-03-25 | — | — | EP | claimed |
| CN-104471391-A | Method for identifying ligands of the AHR receptor having therapeutic sebosuppressive activity, and said ligands | SAURAT JEAN HILAIRE | 2015-03-25 | — | — | CN | claimed |
| WO-2013171696-A1 | METHOD FOR IDENTIFYING LIGANDS OF THE AHR RECEPTOR HAVING THERAPEUTIC SEBOSUPPRESSIVE ACTIVITY, AND SAID LIGANDS | SAURAT JEAN HILAIRE (CH) | 2013-11-21 | — | — | WO | claimed |
| CN-111867634-B | Enhancement of translocation of micro/nanoparticles across mucus layers using alginate oligomers | 阿尔吉法玛公司 | 2024-06-11 | — | — | CN | disclosed |
| EP-0062237-A1 | Process for the determination of the carcinogenicity of chemical or physical agents | YEDA RESEARCH AND DEVELOPMENT COMPANY, LTD. (IL) | 1982-10-13 | — | — | EP | disclosed |